Live Breaking News & Updates on Discovery stage genital herpes

Stay updated with breaking news from Discovery stage genital herpes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genital Herpes Pipeline Landscape: Insights into Emerging Therapies, Growth Variables, Commercial Assessment and Key Pharmaceutical Companies Active in the Space - Press Release

25+ active players in the domain working on 25+ pipeline therapies.
Key Genital Herpes pipeline therapies such as
HSV 2 Vaccines, RVx-201, NE HSV-2 Vaccine, HDIT 101, Pritelivir, UB-621, and others are under investigation in different phases of clinical trials for the treatment of Genital Herpes.
Sanofi, Rational Vaccines, BlueWillow Biologics, Heidelberg, ImmunoTherapeutics, AiCuris, United Biopharma, among several others, are some of the key prominent pharma players working in the domain.
In
May 2021, X-Vax Technology announced that it is preparing to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its experimental vaccine against herpes simplex virus 1 and 2 (HSV-1 and -2).

United-states , Bluewillow-biologics , Los-angeles , Heidelberg-immunotherapeutics , Evofem-biosciences , Squarex-pharma , Key-pharmaceutical-companies , Key-genital-herpes-companies , Drug-administration , Delveinsight-due-diligence-services , Key-companies , Johnson